Sept 30 (Reuters) – The U.S. Food and Drug Administration has approved Novartis' oral treatment for patients with type of chronic inflammatory skin disease, the company said on Tuesday. (Reporting by Siddhi Mahatole in Bengaluru; Editing by Sahal Muhammed)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
A legend on the silver screen, two-time Oscar winner Anthony Hopkins has now brought out…
Berlin (dpa) – For fans, there is nothing like a well-cooked steak, with a crispy…
A teacher and a parenting expert outline key signs the new term is causing issues…
Cologne (dpa) - Take the time to make your own cheese ravioli at home. You…
Remember that spiking can happen to anyone, anywhere, at any time. London (PA Media/dpa) - Thousands…
We have trainers, leggings and sports bras designed specifically for exercise and sweating – but…